Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: a nationwide population-based cohort study in Taiwan
Fu‐Shun Yen, James Cheng‐Chung Wei, Hei‐Tung Yip, Chii‐Min Hwu, Ming‐Chih Hou, Chih‐Cheng Hsu
Topics & Concepts
MedicineCirrhosisInternal medicineHazard ratioDecompensationGastroenterologyType 2 Diabetes MellitusHepatocellular carcinomaDiabetes mellitusDipeptidyl peptidase-4 inhibitorCohortType 2 diabetesPopulationConfidence intervalEndocrinologyEnvironmental healthLiver Disease and TransplantationLiver Disease Diagnosis and TreatmentDiabetes Treatment and Management